This choice of disease was based on the fact that TNF is released in MS and has shown cytotoxic activity against oligodendrocytes, the cells killed in MS by the immune system, and since TNF neutralization has been publicized to be effective in mice with autoimmune encephalitis (a murine model for MS-like illness). This evidence concerns the gene TNF and myeloid sarcoma.